← Back to Search

Corticosteroid

Budesonide irrigation for Chronic Sinusitis

Phase 3
Waitlist Available
Research Sponsored by Université de Sherbrooke
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months after beginning of treatment
Awards & highlights

Summary

This trial is testing whether a nasal spray or a nose irrigation is more effective for people with chronic sinus problems who have not had surgery.

Eligible Conditions
  • Chronic Sinusitis

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months after beginning of treatment
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months after beginning of treatment for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Disease specific quality of life questionnaire
Secondary study objectives
Endoscopic evaluation of the nasal cavities

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Budesonide irrigationExperimental Treatment1 Intervention
2 cc budesonide nebule (0,5 mg/cc) incorporated to 240 of saline water (Sinus Rinse) to be taken on a daily basis x 3 months
Group II: Mometasone nasal sprayActive Control1 Intervention
Mometasone nasal spray 50 mcg/dose, 2 sprays/nostril twice daily x 3 months Patients will also be taking Sinus Rinse once daily throughout the study period

Find a Location

Who is running the clinical trial?

Université de SherbrookeLead Sponsor
302 Previous Clinical Trials
70,227 Total Patients Enrolled
~4 spots leftby Sep 2025